The note reveals that Goldman has initiated coverage with a buy rating and $48.90 price target on ResMed's shares. Based on ...

Indexes closed lower on Thursday, with the tech-heavy Nasdaq falling almost 1%, led by a slide in mega-cap tech stocks like ...

The Dow, S&P 500, and Nasdaq are lower Thursday as the stock market digests the latest corporate earnings results.

More monster gains for the S&P 500, global internet failure, and $600B worth of power outages are events investors should ...

U.S. stock indexes are drifting Thursday following a mixed set of earnings reports from Morgan Stanley, UnitedHealth Group ...

The prolonged slump reflects subdued investor sentiment, as many have reduced their buying activity amid ongoing market uncertainty ...

Discover high-yielding solutions to enhance your dividend investing portfolio and maximize returns. Click here to read what ...

Follow here to see if Wall Street can add to the big gains seen midweek after cooler inflation saw Treasury yields plunge, ...

Consumer Electronics Show (CES) 2025 revolved around AI. If not, it’s all that exhibitors could show. Talking about the ...

Demand for Big Data services is increasing. Palantir, a leader in the field, should benefit. Here are the forecasts and price ...

Wall Street pauses Thursday, with stocks little moved in early trade. Strong bank earnings keep rolling in and Senate ...

Investors have been hoping Donald Trump's return to the White House next week will boost the U.S. stock market, while Goldman ...